��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title What Is the Best Bedside Test To Screen for Cognitive Impairment in ALS?

Topic Anterior Horn

Presentation(s) (-)

Poster/Presentation
Number 086

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Susan Woolley Levine, PhD	No disclosure on file
Dan Moore, PhD (California Pacific Medical Center)	No disclosure on file
Jonathan S. Katz, MD (CPMC)	Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Katz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kedrion. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Griffols.
Bernadette M. Schoneburg, MD (NorthShore University Health Systems)	No disclosure on file
	No disclosure on file